Cargando…

Long-term follow-up for monovision surgery by Implantable Collamer Lens V4c implantation for myopia correction in early presbyopia

PURPOSE: To investigate the long-term safety and efficacy of monovision surgery using implantable collamer lens V4c (ICL V4c) implantation in myopic patients with early presbyopia. SETTING: Eye and ENT Hospital of Fudan University, Shanghai, China. DESIGN: Prospective case series study. METHODS: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Yuhao, Zhao, Jing, Zhang, Zhe, Niu, Lingling, Shi, Wanru, Wang, Xiaoying, Zhou, Xingtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325784/
https://www.ncbi.nlm.nih.gov/pubmed/35129628
http://dx.doi.org/10.1007/s00417-021-05545-x
_version_ 1784757133522239488
author Ye, Yuhao
Zhao, Jing
Zhang, Zhe
Niu, Lingling
Shi, Wanru
Wang, Xiaoying
Zhou, Xingtao
author_facet Ye, Yuhao
Zhao, Jing
Zhang, Zhe
Niu, Lingling
Shi, Wanru
Wang, Xiaoying
Zhou, Xingtao
author_sort Ye, Yuhao
collection PubMed
description PURPOSE: To investigate the long-term safety and efficacy of monovision surgery using implantable collamer lens V4c (ICL V4c) implantation in myopic patients with early presbyopia. SETTING: Eye and ENT Hospital of Fudan University, Shanghai, China. DESIGN: Prospective case series study. METHODS: This study included 64 eyes of 32 patients with early presbyopia, who underwent bilateral ICL V4c implantation for myopia correction. Parameters, including mean spherical equivalent (SE), uncorrected distance visual acuity, corrected distance visual acuity, intraocular pressure, endothelial cell density, presbyopic add power, visual acuity (logMAR) of dominant eyes (D-eye), nondominant (nD-eye) eyes, and both eyes (Bi) at 0.4 m, 0.8 m, and 5 m were recorded at the last follow-up. RESULTS: All surgeries were uneventful. At the last follow-up, the safety indices were 1.23 ± 0.18 (D-eyes) and 1.21 ± 0.18 (nD-eyes) (p > 0.05); the efficacy indices were 0.95 ± 0.27 (D-eyes) and 0.92 ± 0.28 (nD-eyes) (p < 0.05), the SE was -0.62 ± 0.47 D (D-eyes); and − 1.21 ± 0.78D (nD-eyes) (p < 0.05), presbyopic add power was 1.31 ± 0.58 D. The visual acuity (logMAR) of D-eyes, nD-eyes, and binocular (Bi) at 5.0 m were: 0.06 ± 0.15 (D-eye), 0.21 ± 0.18 (nD-eye), (p < 0.01), and 0.04 ± 0.13 (Bi); 0.8 m: 0.03 ± 0.18 (D-eye), 0.08 ± 0.16 (nD-eye), (p > 0.05), and − 0.02 ± 0.11 (Bi); 0.4 m: 0.08 ± 0.09 (D-eye), − 0.02 ± 0.08 (nD-eye), (p < 0.001), and − 0.03 ± 0.09 (Bi). Subjects were very satisfied or felt excellent with their visual acuity at near (81.25%) and far distances (87.50%), respectively (versus preoperative, p < 0.001). CONCLUSION: Monovision surgery using ICL V4c implantation is safe and practicable for correction of myopes with presbyopia, with long-term efficacy at near and far distances and patient satisfaction. [Image: see text]
format Online
Article
Text
id pubmed-9325784
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-93257842022-07-28 Long-term follow-up for monovision surgery by Implantable Collamer Lens V4c implantation for myopia correction in early presbyopia Ye, Yuhao Zhao, Jing Zhang, Zhe Niu, Lingling Shi, Wanru Wang, Xiaoying Zhou, Xingtao Graefes Arch Clin Exp Ophthalmol Refractive Surgery PURPOSE: To investigate the long-term safety and efficacy of monovision surgery using implantable collamer lens V4c (ICL V4c) implantation in myopic patients with early presbyopia. SETTING: Eye and ENT Hospital of Fudan University, Shanghai, China. DESIGN: Prospective case series study. METHODS: This study included 64 eyes of 32 patients with early presbyopia, who underwent bilateral ICL V4c implantation for myopia correction. Parameters, including mean spherical equivalent (SE), uncorrected distance visual acuity, corrected distance visual acuity, intraocular pressure, endothelial cell density, presbyopic add power, visual acuity (logMAR) of dominant eyes (D-eye), nondominant (nD-eye) eyes, and both eyes (Bi) at 0.4 m, 0.8 m, and 5 m were recorded at the last follow-up. RESULTS: All surgeries were uneventful. At the last follow-up, the safety indices were 1.23 ± 0.18 (D-eyes) and 1.21 ± 0.18 (nD-eyes) (p > 0.05); the efficacy indices were 0.95 ± 0.27 (D-eyes) and 0.92 ± 0.28 (nD-eyes) (p < 0.05), the SE was -0.62 ± 0.47 D (D-eyes); and − 1.21 ± 0.78D (nD-eyes) (p < 0.05), presbyopic add power was 1.31 ± 0.58 D. The visual acuity (logMAR) of D-eyes, nD-eyes, and binocular (Bi) at 5.0 m were: 0.06 ± 0.15 (D-eye), 0.21 ± 0.18 (nD-eye), (p < 0.01), and 0.04 ± 0.13 (Bi); 0.8 m: 0.03 ± 0.18 (D-eye), 0.08 ± 0.16 (nD-eye), (p > 0.05), and − 0.02 ± 0.11 (Bi); 0.4 m: 0.08 ± 0.09 (D-eye), − 0.02 ± 0.08 (nD-eye), (p < 0.001), and − 0.03 ± 0.09 (Bi). Subjects were very satisfied or felt excellent with their visual acuity at near (81.25%) and far distances (87.50%), respectively (versus preoperative, p < 0.001). CONCLUSION: Monovision surgery using ICL V4c implantation is safe and practicable for correction of myopes with presbyopia, with long-term efficacy at near and far distances and patient satisfaction. [Image: see text] Springer Berlin Heidelberg 2022-02-07 2022 /pmc/articles/PMC9325784/ /pubmed/35129628 http://dx.doi.org/10.1007/s00417-021-05545-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Refractive Surgery
Ye, Yuhao
Zhao, Jing
Zhang, Zhe
Niu, Lingling
Shi, Wanru
Wang, Xiaoying
Zhou, Xingtao
Long-term follow-up for monovision surgery by Implantable Collamer Lens V4c implantation for myopia correction in early presbyopia
title Long-term follow-up for monovision surgery by Implantable Collamer Lens V4c implantation for myopia correction in early presbyopia
title_full Long-term follow-up for monovision surgery by Implantable Collamer Lens V4c implantation for myopia correction in early presbyopia
title_fullStr Long-term follow-up for monovision surgery by Implantable Collamer Lens V4c implantation for myopia correction in early presbyopia
title_full_unstemmed Long-term follow-up for monovision surgery by Implantable Collamer Lens V4c implantation for myopia correction in early presbyopia
title_short Long-term follow-up for monovision surgery by Implantable Collamer Lens V4c implantation for myopia correction in early presbyopia
title_sort long-term follow-up for monovision surgery by implantable collamer lens v4c implantation for myopia correction in early presbyopia
topic Refractive Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325784/
https://www.ncbi.nlm.nih.gov/pubmed/35129628
http://dx.doi.org/10.1007/s00417-021-05545-x
work_keys_str_mv AT yeyuhao longtermfollowupformonovisionsurgerybyimplantablecollamerlensv4cimplantationformyopiacorrectioninearlypresbyopia
AT zhaojing longtermfollowupformonovisionsurgerybyimplantablecollamerlensv4cimplantationformyopiacorrectioninearlypresbyopia
AT zhangzhe longtermfollowupformonovisionsurgerybyimplantablecollamerlensv4cimplantationformyopiacorrectioninearlypresbyopia
AT niulingling longtermfollowupformonovisionsurgerybyimplantablecollamerlensv4cimplantationformyopiacorrectioninearlypresbyopia
AT shiwanru longtermfollowupformonovisionsurgerybyimplantablecollamerlensv4cimplantationformyopiacorrectioninearlypresbyopia
AT wangxiaoying longtermfollowupformonovisionsurgerybyimplantablecollamerlensv4cimplantationformyopiacorrectioninearlypresbyopia
AT zhouxingtao longtermfollowupformonovisionsurgerybyimplantablecollamerlensv4cimplantationformyopiacorrectioninearlypresbyopia